KEGG   DRUG: Tositumomab
Entry
D08621                      Drug                                   

Name
Tositumomab (INN)
Efficacy
Antineoplastic, Immunomodulator, Anti-CD20 antibody
Comment
Monoclonal antibody
Target
CD20 [HSA:931] [KO:K06466]
  Pathway
hsa04640  Hematopoietic cell lineage
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   CD molecules
    CD20
     D08621  Tositumomab (INN)
Other DBs
CAS: 208921-02-2
PubChem: 96025305
DrugBank: DB00081
NIKKAJI: J2.415.688E
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system